RUNX1 germline variants in RUNX1-mutant AML: how frequent?

Ernst, Martijn P T; Kavelaars, François G; Löwenberg, Bob; Valk, Peter J M; Raaijmakers, Marc H G P

Ernst, Martijn P T; Kavelaars, François G; Löwenberg, Bob; Valk, Peter J M; Raaijmakers, Marc H G P.

Affiliation

Ernst MPT; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.
Kavelaars FG; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.
Löwenberg B; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.
Valk PJM; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.
Raaijmakers MHGP; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.

Blood ; 137(10): 1428-1431, 2021 03 11.

Article in En | MEDLINE | ID: mdl-33075818

Subject(s)

Core Binding Factor Alpha 2 Subunit/genetics; Leukemia, Myeloid, Acute/genetics; Adult; Cohort Studies; Female; Gene Frequency; Germ-Line Mutation; Humans; Male; Middle Aged; Mutation; Point Mutation

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Core Binding Factor Alpha 2 Subunit Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2021 Type: Article Affiliation country: Netherlands

Fulltext

XML

PubMed Links

Search on Google